Skip to main content

Metavone seeks ASX listing

03/10/2016 - 10:52

Bookmark

Save articles for future reference.

Perth-based biotechnology company Metavone hopes to list on the ASX next month after raising up to $5 million from investors in an initial public offering.

X

To read our articles you will need to either login or subscribe.